4,4'-dithiodimorpholine has been researched along with Papillomavirus Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbell, M; Hampson, IN; Hampson, L; Lee, KF; Richard, C; Zehbe, I | 1 |
Beerheide, W; Bernard, HU; Ganesan, A; Rice, WG; Tan, YJ; Ting, AE | 1 |
2 other study(ies) available for 4,4'-dithiodimorpholine and Papillomavirus Infections
Article | Year |
---|---|
Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions.
Topics: Antiviral Agents; Azo Compounds; Cell Line, Tumor; Diamide; Female; HIV Protease Inhibitors; Humans; Keratinocytes; Lethal Dose 50; Lopinavir; Microbial Sensitivity Tests; Morpholines; Papillomaviridae; Papillomavirus Infections; Pyrimidinones | 2011 |
Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein.
Topics: Amino Acid Sequence; Antineoplastic Agents; Apoptosis; Blotting, Western; Calcium-Binding Proteins; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Glutathione; Glutathione Transferase; Humans; Ligases; Molecular Sequence Data; Morpholines; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Protein Binding; Protein Biosynthesis; Recombinant Fusion Proteins; Repressor Proteins; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Virus Infections; Ubiquitin-Protein Ligases; Uterine Cervical Neoplasms; Zinc; Zinc Fingers | 1999 |